Japan commits to comparability protocols for drugs as ICH Q12 takes shape
This article was originally published in SRA
Executive Summary
In an important advance toward continual improvement of global pharmaceutical manufacturing processes, a Japanese regulatory official has promised that his agency will make it possible to use comparability protocols in Japan.